News

Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering
Oppenheimer & Co. Inc. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.
Cue Biopharma to Host Business Update Call and Webcast
Conference Call and Webcast Details Tuesday, April 15 at 4:30 p.m. ET ...